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ABSTRACT
Human GEN1 and yeast Yen1 are endonucleases with
the ability to cleave Holliday junctions (HJs), which
are proposed intermediates in recombination. In
vivo, GEN1 and Yen1 function secondarily to Mus81,
which has weak activity on intact HJs. We show that
the genetic relationship is reversed in Drosophila,
with Gen mutants having more severe defects than
mus81 mutants. In vitro, DmGen, like HsGEN1, effi-
ciently cleaves HJs, 5′ flaps, splayed arms, and repli-
cation fork structures. We find that the cleavage rates
for 5′ flaps are significantly higher than those for HJs
for both DmGen and HsGEN1, even in vast excess
of enzyme over substrate. Kinetic studies suggest
that the difference in cleavage rates results from a
slow, rate-limiting conformational change prior to HJ
cleavage: formation of a productive dimer on the HJ.
Despite the stark difference in vivo that Drosophila
uses Gen over Mus81 and humans use MUS81 over
GEN1, we find the in vitro activities of DmGen and
HsGEN1 to be strikingly similar. These findings sug-
gest that simpler branched structures may be more
important substrates for Gen orthologs in vivo, and
highlight the utility of using the Drosophila model
system to further understand these enzymes.
INTRODUCTION
Recombination is an integral process for DNA damage re-
pair as well as for horizontal gene transfer during conjuga-
tion or transduction (1). Robin Holliday proposed a molec-
ular model for recombination that included a four-stranded
intermediate linking two DNA helices (2). Support for the
existence of this intermediate, now termed a Holliday junc-
tion (HJ), came from electron microscopy of phage lambda
DNA undergoing recombination in Escherichia coli (3). In
vitro synthetic HJ cleavage assays using prokaryotic en-
zymes, like RuvC, provided the first direct evidence for the
existence of structure-selective endonucleases (SSEs) capa-
ble of HJ cleavage, termedHJ resolvases (4). Prokaryotic re-
solvases show preference for HJs over other DNAbranched
structures and cleave symmetrically about the HJ axis, cre-
ating duplex DNA products with a nick that can be ligated
without additional processing (5). Their in vivo resolvase
function was evident in that mutations in the genes encod-
ing these enzymes led to reduced recombination and sen-
sitivity to DNA damaging agents (6). These properties be-
came the benchmark for defining canonical resolvases.
The in vivo and in vitro evidence for resolvase function
in bacteria led to the search for similar activities and genes
in eukaryotes. Electron microscopy of yeast recombination
intermediates provided visual evidence that eukaryotic re-
combination can involve Holliday junction intermediates
(7). Extensive in vitro studies of HJ cleavage activity identi-
fied Yen1 in budding yeast and GEN1 in human cells (8,9),
as well as the MUS81–EME1–SLX1–SLX4 complex (here-
after called MUS–SLX complex) in humans and mice (10–
12). HsGEN1 dimerizes on HJs to coordinate symmetrical
cleavage across the HJ, whereas MUS–SLX resolves HJs
through the coordination of a nick by SLX1with a counter-
nick by MUS81–EME1.
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Although GEN1 and the MUS–SLX complex display
canonical resolvase activity similar to that of prokaryotic
resolvases, their biochemical properties differ from those of
prokaryotic resolvases in that the eukaryotic enzymes are
not obligate homodimers and they cleave other branched
DNA structures such as flaps, replication forks, and nicked
HJs (8–12). Furthermore, mutations in the genes encoding
these enzymes do not cause the same recombination defects
and DNA damage sensitivities that occur when bacterial
resolvases are knocked out. Loss of Mus81 results in hy-
persensitivity to a broad range of DNA damaging agents
(13–15), but hypersensitivities resulting from loss of Slx1
are weaker to a non-overlapping set of damaging agents
(10,16). These findings suggest that many of Mus81’s re-
pair functions lie outside of a MUS–SLX complex. GEN1
resolvase is genetically less complicated because it only in-
volves one gene. However, mutations in S. cerevisiae YEN1
or murine Gen1 do not cause any apparent DNA repair
defects on their own, but they do increase the severity of
mus81 mutant phenotypes in double mutants, suggesting
that Yen1/Gen1 act primarily as backups to Mus81 (17–
20). Consequently, one of the primary challenges to char-
acterizing Yen1/GEN1 has been the need to study the null
effect in the background of null mutations in other endonu-
cleases.
Drosophila provides a unique platform for understanding
functions of Yen1/GEN1 because the hierarchical relation-
ship between DmGen and Mus81 appears to be reversed.
Unlike in other organisms, Drosophila mus81 mutants are
hypersensitive to only a few DNA damaging agents, and
then only mildly (21). Furthermore, in the absence of the
DNA repair helicase Blm, loss of DmGen causes a much
more severe phenotype (death early in larval development)
than loss of Mus81 (death late in pupal development) (22).
Here, we confirm thatDmGen is important inDNAdam-
age repair by showing that, unlike in yeast and mammalian
cells, Gen single mutants are severely hypersensitive to sev-
eral different DNA damaging agents. We show that, like its
human ortholog, DmGen efficiently cleaves HJs, 5′ flaps,
splayed arms, and replication fork structures. We find that
the cleavage rate for 5′ flaps is significantly higher than the
cleavage rate for HJs. Kinetic studies suggest that the dif-
ference in cleavage rates results from a slow, rate-limiting
conformational change prior to HJ cleavage: formation of
a productive dimer on the HJ. We comparedDmGen to hu-
man GEN1 in side-by-side experiments. While slight dif-
ferences such as the propensity to dimerize do exist be-
tween DmGen and HsGEN1, we find the activities of the
orthologs to be strikingly similar, including the higher cleav-
age rate on flaps than on HJs. These findings suggest that
simpler branched structures may be more important sub-
strates for Gen orthologs in vivo, and they highlight the util-
ity of using the Drosophila model system to further under-
stand this class of enzymes.
MATERIALS AND METHODS
Drosophila stocks and genetics
All stocks were maintained at 25◦C on standard media.
The following null mutations were described previously:
mus81NheI (21) and GenZ5997 (22), which was made hem-
izygous with Df(3L)6103. Sensitivity to DNA damaging
agents was done as described previously (23). For nitrogen
mustard (HN2), hydroxyurea (HU), and methylmethane
sulfonate (MMS), 250 l water containing the agent at the
indicated concentration were added to each vial contain-
ing feeding larvae. Camptothecin (CPT) was dissolved in
DMSO and diluted in 10% ethanol and 0.2% Tween; con-
trol larvae were treated with DMSO only. For IR, vials with
third instar larvae were irradiated with 20 Grays from a
137Cs source (GammaCell GG10). Progeny were scored for
5 days after eclosion began. Relative survival was calculated
as the ratio of mutant to control flies per vial and was nor-
malized to the ratio in untreated vials. Statistical analyses
were done using Prism (GraphPad, San Diego, CA, USA).
Purification of full-length and truncated Gen (1–518) fromE.
coli
DmGen cDNA was codon-optimized by GenScript. Full-
length DmGen (1–726 aa) and truncated DmGen (1-518
aa) were cloned into the NdeI and XhoI sites of pET21b
(Novagen, Madison, WI), which carries a C-terminal hex-
ahistidine tag (His). The nuclease-dead mutations E143A
and E145A, previously described by (24), were made by
QuikChange site-directed mutagenesis (Agilent Technolo-
gies, Santa Clara, CA, USA). DmGen-His was expressed
in RDK cells (gift of Dr. Steve Matson) with 0.4 mM
IPTG, and DmGen (1–518)-His was expressed in Rosetta
II pLysS (Novagen) with 1.0 mM IPTG. All proteins were
expressed at 18◦C for 18 h. The DmGen (1–518)-His and
DmGen (1–518)Dead-His pellets were lysed inNiA buffer (20
mM KH2PO4 pH 7.0, 100 mM ammonium acetate, 1 mM
TCEP, 0.02% sodium azide, 500 mM NaCl, 50 mM imi-
dazole), sonicated, pelleted, and the clarified supernatant
was loaded onto a 5 ml HisTrap HP column (GE Health-
care Life Sciences, Pittsburgh, PA) and eluted with NiB (20
mM KH2PO4 pH 7.0, 100 mM ammonium acetate, 1 mM
TCEP, 0.02% sodium azide, 500 mMNaCl, 500 mM imida-
zole). Peak fractions were diluted in NiA minus salt to 50
mMNaCl and loaded onto a 6 ml Resource S column (GE
Healthcare Life Sciences) pre-equilibrated with MonoSA
(20 mM KH2PO4 pH 7.0, 100 mM ammonium acetate, 1
mM TCEP, 0.02% sodium azide, 50 mM NaCl) and gra-
dient eluted with MonoSB (20 mM KH2PO4 pH 7.0, 100
mM ammonium acetate, 1 mMTCEP, 0.02% sodium azide,
1 M NaCl). Peak fractions were concentrated to 5 ml and
loaded onto a Superdex S200 column (GE Healthcare Life
Sciences) and eluted with S200 buffer (50 mM HEPES
pH 7.0, 400 mM NaCl, 100 mM ammonium acetate, 1
mM TCEP, 0.02% sodium azide). Full-length DmGen-His
and DmGenDead-His were purified over HisTrap and S200
columns. Following elution from the S200 column, purity
was assessed by dynamic light scattering and SDS-PAGE.
DmGen (1–518)-His was dialyzed into high salt buffer
(25 mM HEPES pH 7.5, 100 mM sodium acetate, 10 mM
magnesium acetate, 5% glycerol, 1 mM DTT) before injec-
tion onto a Superdex 200 column (GE Healthcare Life Sci-
ences) connected to a DAWNHELEOS-II (Wyatt Technol-
ogy Corporation, Santa Barbara, CA, USA) light scatter-
ing instrument and a Optilab T-rEX refractometer (Wyatt
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Technology Corporation). The Astra V software package
(Wyatt Technology Corporation) was used to determine the
molar mass of the sample.
Nuclease assays
Synthetic DNA substrates were prepared by anneal-
ing oligonucleotides, shown in Supplementary Table S1.
Oligonucleotides (oligos) 888, 891, 892, 893, 894, 895,
897, 992 were described previously (25); 940, 994, 888+10,
990+10 were modified from these. These oligos were used
to form the majority of substrates used in this study, termed
‘Bellendir substrates’. Oligos 1, 2, 3, 4 and 7 were described
previously (26) and were used to form the ‘Rass substrates’
used in Figure 5. All substrates were prepared as previ-
ously described (27). Briefly, one oligonucleotidewas 5′ end-
labeled using T4 polynucleotide kinase and  -32PATP. Sub-
strates were annealed in annealing buffer (50 mM Tris pH
7.5, 10 mM MgCl2, 50 mM NaCl, 5 mM DTT), PAGE-
purified, and quantified by A260.
For nuclease assays, tr-DmGen-His (1–518-His) or tr-
HsGEN1-His (1–527) (gift of Dr. Steve West) was incu-
batedwith the 32P-labeled structures in a 10l reactionmix-
ture containing 50 mM Tris pH 8, 100 g/ml BSA, 1 mM
DTT, 10% glycerol, 50 mM KCl, and 5 mM MgCl2 (Bel-
lendir buffer––used in all kinetic experiments unless other-
wise stated) or 60mMsodiumphosphate pH7.4, 100g/ml
BSA, 1 mM DTT, and 5 mM Mg(OAc)2 (Rass buffer) at
either room temperature for reactions containing DmGen
or 37◦C for reactions containing HsGEN1. For fixed end-
point assays, unless otherwise indicated, 20 nM protein was
incubated with 1 nM substrate. For ligation of products,
1 U of T4 DNA Ligase (NEB) was incubated at 22◦C for
30 min. The reaction was stopped by adding an equal vol-
ume of formamide loading dye (85% formamide, 50 mM
ethylenediaminetetraacetic acid (EDTA), 1% bromophenol
blue, 1% xylene cyanol), heated at 95◦C for 5 min, and a
fraction was loaded onto a polyacrylamide gel. After elec-
trophoresis, gels were dried and imaged on aTyphoonTrio+
(GEHealthcare Life Sciences). Bands were quantified using
ImageQuant (GE HealthCare Life Sciences).
For the kinetic analysis, the experiments were conducted
by two methods: (i) simultaneous addition, in which the
reaction was initiated by the simultaneous addition of
DmGen or HsGEN1, Mg2+ and DNA, and (ii) prebinding
analysis, in which,DmGen and either 5′ flap orHJ0 were in-
cubated together for a fewminutes before the reactions were
initialized with the addition of MgCl2. For time points, 1
l aliquots were removed and quenched in 2.5 mg/ml Pro-
teinase K, 2.5% SDS, and 125 mM EDTA. The amounts of
protein and substrate used in the kinetics assays are given
in the figure legend. To determine the percentage substrate
cleaved, the amount of product was calculated as a frac-
tion of the total radioactivity per lane. For the HJ0, only
half the cleavage products (those in which the labeled strand
is cut) are detected. Conversely, the HJ-Rass structure dis-
played propensity to adopt a specific orientation that leads
to biased cleavage orientation (28). To account for this, rates
were determined from native gels. For the 5′ flap, a frac-
tion of the substrate was unproductive or degraded. To ac-
count for this non-functional substrate, data were normal-
ized to the expected amount of detectable product. The ap-
parent pseudo first-order rate constant, kapp, for each con-
centration was determined by fitting the full reaction curves
to a single-exponential function [(y = A*exp(kappt) + C]
using KaleidaGraph software (Synergy Software, Reading,
PA, USA). To examine the concentration dependence of the
rates of cleavage of the flap an HJ0, kapp was plotted as
a function of DmGen concentration, and these plots were
fit to hyperbolic binding curves to determine the apparent
binding affinity, K1/2, of DmGen to the flap or HJ0, using
KaleidaGraph.
DNA-binding assays
DmGen (1–518)-His was incubated in a 10 l reaction with
50 pM 32P-labeled DNA in binding buffer (10 mMHEPES
pH 7.5, 100 g/ml BSA, 1 mM DTT, 5% glycerol, 60 mM
KCl) containing 5 mMEDTA. Incubation was at RT for 30
min. Reactions were immediately analyzed by 4% neutral
PAGE at 4◦C. After running, gels were either dried or ex-
posed overnight at –80◦C and imaged on a Typhoon Trio+
(GEHealthcare Life Sciences). Bands corresponding to un-
bound and boundDNAwere quantified using ImageQuant
(GEHealthCare Life Sciences). TheK1/2 of binding and the
Hill co-efficient for the binding of the HJ0 or the 5′ flap was
determined by fitting the data usingKaleidaGraph software
(Synergy Software, Reading, PA) and applying the follow-
ing equation:




where θ is the fraction of total substrate that is bound, θmax
is the maximum fraction of substrate bound, p is the protein
concentration, and n is the Hill coefficient. K1/2 is the con-
centration at which half of the substrate is bound by protein
and KD = (K1/2)n.
Expression of Gen in S. pombe and sensitivity analysis
Strains, RusA plasmids, and pREP41 plasmids are listed in
Supplementary Table S2. Transformations were performed
using the lithium acetate-based method described previ-
ously (29). For spot tests, strains containing plasmids were
grown to saturation in EMM2−leucine dropout medium,
washed twice with water, diluted to OD600 = 1, and 10-fold
serially diluted to 10−4 cells/ml. Ten microliters aliquots
from each dilution were spotted onto minimal medium
plates containing MMS, CPT, HU or BLEO, then incu-
bated at 32◦C for 4 days before being photographed.
Immunofluorescence microscopy
Polyclonal antibodies were raised to a peptide spanning
residues 236–335 of DmGen and affinity-purified by Ge-
nomic Antibody Technology (SDIX, Newark, DE, USA).
All imaging was done with a laser-scanning confocal mi-
croscope (710, Carl Zeiss) and analyzed with ImageJ.
For embryo staining, 2–3 h old embryos were dechori-
onated, fixed in equal volumes 7% formaldehyde:heptane,
devittelinized, and then stained. The primary antibody was
rabbit anti-DmGen-N (1:1000), which was visualized with
goat anti-rabbit IgG (H+L)-Alexa Fluor 488 (1:500, Life
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Technologies). DAPI (1:1000) staining was done for 2 min
at room temperature.
For Drosophila S2 cells, DmGen cDNA was cloned into
the pMT-V5-HisA vector (Life Technologies), which con-
tains the CuSO4-inducible metallothionein promoter and
a C-terminal His tag. The construct was stably trans-
fected into S2 cells. Cells were plated at 1×106 cells/ml
on poly-L-lysine-treated coverslips. DmGen-His expression
was induced for 3 days before staining. Staining was per-
formed as in (30). The primary antibodies were rabbit anti-
DmGen-N (1:10 000) and mouse anti-His (1:500). The pri-
mary antibodies were visualized with goat anti-rabbit IgG
(H+L)-Alexa Fluor 488 (1:10,000) and goat anti-mouse
IgG (H+L)-Alexa Fluor 555 (1:10 000, Life Technologies).
DNAwas detected by staining with DAPI (1:5000, Thermo
Fisher Scientific, Carlsbad, CA, USA) for 1 min at room
temperature.
Atomic force microscopy
50 M DmGen (1–518)-His was diluted to 2 M in stor-
age buffer (50 mM HEPES pH 7.0, 400 mM NaCl, 100
mM ammonium acetate, 1 mM TCEP, 10% glycerol) and
then to 20 and 37 nM in high salt buffer (25 mM HEPES
pH 7.5, 100 mM sodium acetate, 10 mM magnesium ac-
etate, 5% glycerol, 1 mM DTT) and 20 l was immediately
deposited onto freshly-cleaved mica. The mica surface was
then immediately washed with water, and a stream of nitro-
gen gas was used to dry the surface. Images were acquired
with a Nanoscope IIIA atomic force microscope (Veeco,
Santa Barbara, CA, USA) in tapping mode with a resolu-
tion of 512 × 512 pixels at a scan rate of 1.97 Hz and over
a 1 × 1 m scan size. AFM tips were from NanoSensors
(Neuchatel, Switzerland) with a spring constant between 21
and 98 N/m and resonance frequencies between 146 and
236 kHz. AFM images for the samples were consistent over
two depositions and multiple tips (at least two for each
deposition). Poor images resulting from blunted tips were
excluded from analysis. At least seven representative im-
ages of each sample were second order plane-fitted and flat-
tened, and three-dimensional images were generated using
NanoScope Analysis version 1.53r1 (Bruker Corporation,
Billerica, MA, USA). Volume analysis of protein peaks was
conducted with Image SXM 195-1 (Steve Barrett, Univer-
sity of Liverpool, UK) as described in (31). Volumes corre-
sponding to protein aggregates were excluded from analy-
sis. Volume plots were generated using KaleidaGraph 4.1.3
(Synergy Software). Protein molecular mass was converted
into predicted AFM volume using the following equation:
V = 1.2 ∗ M− 14.7
where V is AFM volume in nm3, andM is molecular mass
in kDa (32).
Sequence alignments
Sequence alignments were performed using ClustalX 2.1
(33) and edited in GeneDoc version 2.7.000 (34).
RESULTS
DmGen mutants are more sensitive to DNA damage than
mus81 mutants
In yeast and humans, Yen1 and GEN1 seem to act in
DNA damage repair secondarily to Mus81 (17,19,20,35).
This relationship seems to be switched in Drosophila as
previous studies show that flies mutant in Gen and Blm,
which encodes a helicase that can participate in dissolu-
tion of double-HJs, die earlier in development thanMus81
Blm double mutants (22). To more thoroughly assess the
relationship between DmGen and Mus81, we examined
the sensitivity of single and double mutants to a variety
of DNA damaging agents (Figure 1). To investigate ef-
fects on replication-associated damage, we used (a) camp-
tothecin (CPT), a topoisomerase I poison that results in
replication-associated DSBs (36); (b) methyl methanesul-
fonate (MMS), an alkylating agent that induces lesions
that can block replication forks (37) and (c) hydroxyurea
(HU), which inhibits ribonucleotide reductase, leading to
decreased dNTP pools and fork slowing and stalling (38).
Wild-type flies are not sensitive to these agents at the doses
tested (Figure 1). Gen mutants show significant sensitiv-
ity to each agent, indicating an important role in respond-
ing to replication-associated damage (Figure 1A–C). Con-
versely, mus81 mutants do not show sensitivity to CPT or
MMS; however, mus81 Gen double mutants have more se-
vere sensitivity than Gen single mutants, indicating a sec-
ondary role for Mus81 in repairing damage during replica-
tion (Figure 1A and B). Interestingly, mus81 mutants are
healthier than wild-type flies following HU treatment (Fig-
ure 1C) (21), and the mus81 Gen double mutant does not
show increased sensitivity compared to the Gen single mu-
tant. These data indicate that in flies, DmGen facilitates
repair of HU-induced stalled or slowed replication forks,
whereas Mus81 may exacerbate problems caused by HU.
We treated larvae with mechlorethamine (HN2) and ion-
izing radiation (IR) to investigate sensitivity to interstand
crosslinks and DSBs, respectively. Genmutants were signif-
icantly more sensitive to both agents, with mus81 mutants
showing sensitivity only to HN2 (Figure 1D and E); how-
ever mus81 Gen double mutants are significantly more sen-
sitive to IR (Gen single mutants were already completely in-
viable at the tested dose of HN2), suggesting that Mus81
may play a backup role to DmGen in DSB repair (Figure
1D and E).
In summary, Genmutants are more sensitive than mus81
mutants to all of the DNA damaging agents tested (Fig-
ure 1). The increased sensitivity of mus81 Gen double mu-
tants indicates that in flies, Mus81 plays a secondary role
to DmGen. These findings contrast with data from yeast
and human cells that show that Yen1/GEN1 is secondary
to MUS81 (17,19,20,35).
DmGen rescues the DNA-damage sensitivity of S. pombe
mus81 mutants
The sensitivity of DmGen mutants to DNA damaging
agents could indicate that DmGen functions to cut recom-
bination intermediates. To test this possibility, we took ad-
vantage of fission yeast Schizosaccharomyces pombe, which
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Figure 1. Drosophila Gen mutants are more sensitive to DNA damaging agents than mus81 mutants. Graphs show survival of mutants relative to control
siblings (see Materials and Methods). (A) 0.025 mM camptothecin (CPT); (B) 0.04% methyl-methane sulfonate (MMS); (C) 70 mM hydroxyurea (HU);
(D) 0.004% nitrogen mustard (HN2); (E) 2000 rads ionizing radiation (IR). Each point corresponds to one vial; means and 95% confidence intervals are
shown. Dotted lines indicate 100% relative survival (note that Y axes differ between treatments). Paired t-tests between mutant and control individuals
were done to evaluate sensitivity of mutants to each treatment; statistical significance of sensitivity is indicated below each genotype. Differences between
genotypes were assessed by one-way ANOVA and are indicated above each graph. n.s. = not significant (P > 0.05); **P < 0.01; ***P < 0.001; ****P <
0.0001.
has amus81 ortholog but no Yen1/GEN1 ortholog (13,14).
TruncatedHsGEN1 (residues 1–527) expressed in S. pombe
mus81mutants rescues sensitivity toDNAdamaging agents
(39). Similarly, we find that expression of a truncated form
of DmGen (residues 1–518, similar to truncated HsGEN1
(39)) rescues sensitivity of mus81Δ mutants to MMS, CPT,
HUand the radiomimetic drug bleomycin (BLEO) (Supple-
mentary Figure S1A). This rescue is dependent on DmGen
nuclease activity, as expression of nuclease-dead DmGen
has a dominant-negative effect, resulting in less growth
than seen in the negative control (Supplementary Figure
S1A). This effect, which is also seen with nuclease-dead
HsGEN1 or budding yeast Yen1 (17,39), strongly suggests
that the catalytically inactive enzymes bind repair interme-
diates and block alternative repair pathways. We conclude
that DmGen (1–518) is functional in vivo in the repair of
DNA damage in mus81Δ mutants, suggesting that despite
their different genetic phenotypes, HsGEN1 and DmGen
share one or more critical activities that can compensate for
loss of Mus81 activity.
DmGen localizes to the cytoplasm of early embryos and S2
cells
The reversed roles of DmGen and Mus81 in Drosophila rel-
ative to humans and yeast could indicate differences in ac-
cess to the damaged DNA as a result of different cellular
localizations. The activity of human GEN1 and yeast Yen1
is limited to cells undergoing mitosis by protein localiza-
tion and/or activation. Specifically,HsGEN1 is sequestered
in the cytoplasm until nuclear membrane breakdown, and
yeast Yen1’s activity and access to the nucleus are controlled
by dephosphorylation (40–42). A previous study using a
polyclonal antibody to DmGen suggested that it localizes
to the nucleus of 0–3 h old embryos (24). To further assess
DmGen localization, we generated a polyclonal antibody to
a different epitope (residues 236–335). Immunofluorescence
using this antibody reveals that DmGen localizes largely or
exclusively to the cytoplasm in wild-type embryos (Supple-
mentary Figure S2A). Because this result contrasts with the
previous study, we further confirmed cytoplasmic localiza-
tion in cultured cells by overexpression of DmGen carrying
a C-terminal hexahistadine (His) tag under control of an
inducible promoter (Supplementary Figure S2B). A small
fraction of uninduced cells show leaky expression of His-
tagged DmGen, as evidenced from the strong staining by
the His antibody; most of the uninduced cells showed only
background staining with the His antibody but show sig-
nificant staining throughout the cytoplasm with our poly-
colonal antibody to DmGen, suggesting that this cytoplas-
mic protein is endogenous DmGen (Supplementary Figure
S2B, top panels). After induction, both anti-DmGen and
anti-His antibodies detect high levels of a cytoplasmic pro-
tein, with no detectable signal in interphase nuclei (Supple-
mentary Figure S2B, bottom panels). These results strongly
suggest that our antibody binds toDmGen in cells and that
DmGen, like Yen1 andHsGEN1, is primarily or exclusively
cytoplasmic during interphase.While we cannot exclude the
possibility that a low level of nuclear DmGen escaped our
detection, our results imply that the genetic differences be-
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tween DmGen and its orthologs are not simply due to dif-
ferences in gross protein localization.
DmGen cuts 5′ flaps, replication forks, splayed arms andHol-
liday junctions
The in vivo data strongly suggest that DmGen, like its or-
thologs, is a structure-specific endonuclease and might have
Holliday junction resolvase activity. In previous in vitro
experiments, N-terminal 6xHis-tagged DmGen exhibited
weak activity on 5′ flaps, double flaps, and replication forks,
but no activity on HJs (24). These results contrast with the
strong activity seen with recombinant HsGEN1 and Yen1
which were tagged on the C-terminus, and the recent crys-
tal structures of GEN1 from the thermophilic yeastC. ther-
mophilum (CtGEN1) and humans (HsGEN1) implicate the
N-terminal region in cleavage (8,9,43–46). We considered
the possibility that a tag near the N-terminal nuclease do-
main might impact cleavage activity of DmGen and sought
to compare N-terminally and C-terminally tagged proteins.
We expressed and purified both N- and C-terminal
tagged DmGen in full-length and truncated (1–518) forms
(Supplementary Figure S3A and B). To examine substrate
specificity, we incubated DmGen with radiolabeled DNA
substrates. The nuclease activity of the N-terminal-tagged
proteins on the 5′ flap is weak (∼3% cut), but the C-
terminal-tagged versions of DmGen show high activity
(92% cut), with no evidence of contaminating nuclease ac-
tivity (Supplementary Figure S3C and S4C). Both full-
length and truncated C-terminal His-tagged DmGen ex-
hibit robust cleavage of 5′ flaps, replication fork-like struc-
tures (RFs), splayed arms (SAs), and fixed, mobile, and
nicked HJs (Figure 2A; Supplementary Figure S4). We did
not detect cleavage of unbranched dsDNA, nicked duplex
DNA, or 3′ flaps (Figure 2A; Supplementary Figure S4).
Yen1 and HsGEN1 have not been shown to cleave SAs
(8,40). To determine whether DmGen’s cleavage of the SA
is a novel substrate specificity, we tested whether our sub-
strates were cleaved differently by DmGen than by Hs-
GEN1 (Supplementary Figure S5). We see that like Dm-
Gen, HsGEN1 cleaves SAs, and cuts our 5′ flap andHJ sub-
strates at the same sites (Supplementary Figure S5).
Analysis of the cleavage products by denaturing polyacry-
lamide gel electrophoresis (PAGE) reveals that the predom-
inant cut sites are approximately at or one nucleotide (nt) 3′
of the junction branch point on the 5′ flap, RF and SA (Fig-
ure 2A; Supplementary Figures S4 and S5). On the mobile
HJ12 substrate, which contains a 12 bp homologous core
within which the junction can migrate, we observe multiple
cut sites, all within the 12 bp core (Figure 2A; Supplemen-
tary Figure S4). TomapHJ cleavage sites on all four strands
of the HJ0, we alternately labeled each strand of the immo-
bile HJ0 structure (Supplementary Figure S6). The major
cut sites appear to be at the junction and/or one to two
nt 3′ to the junction branch point (Supplementary Figure
S6). To further analyze the cleavage of the HJ0, we created
a derivative of theHJ0 termedHJ0+10nt by annealing one la-
beled strand of∼50 nt, one unlabeled strand of∼50 nt, and
two unlabeled strands of ∼60 nt (Figure 2B and C). This
junction allows us to determine if DmGen cuts symmetri-
cally about the axis to produce nicked duplex products that
can be ligated. If the HJ cleavage products can be ligated, a
new band corresponding to a ∼60 nt DNA will appear on
the gel in the presence of ligase but not its absence (Figure
2B). Analysis of the cleavage and ligation products of the
HJ0+10nt substrate reveals ∼55% detectable product upon
cleavage alone. Incubation of cleavage products with T4 lig-
ase shows a new 60 nt band (30% of total) and a reduction
of the cleaved product (25% of total) (Figure 2C). These
data show that DmGen, like HsGEN1, exhibits canonical
resolvase activity in addition to robust endonuclease activ-
ity on 5′ flaps, RFs and SAs.
Because full-length and truncated C-terminally-tagged
DmGen have similar substrate specificities and activities,
and the truncated protein shows activity in S. pombe (Fig-
ure 2; Supplementary Figures S1–S4), we used themore sta-
ble truncated protein in subsequent in vitro experiments; for
simplicity, we refer to this truncated protein as DmGen.
DmGen can dimerize on DNA substrates
HsGEN1 and CtGEN1 are monomers in solution and
dimerize on HJs (8,9,43). We analyzed DmGen by size-
exclusion chromatography with multi-angle light scattering
(SEC-MALS) after affinity and ion-exchange chromatogra-
phy steps and compared it to a BSA standard (Supplemen-
tary Figure S7). BSA eluted from the column in three dis-
tinct peaks, with the monomer (66 kDa) eluting between 14
and 15 min. The majority of DmGen elutes as a monomer,
exhibiting an average molecular weight of ∼58 kDa (pre-
dicted 60 kDa), however there is a small amount of dimer
present. (Supplementary Figure S7B). To further explore
possible dimerization of DmGen, we used atomic force mi-
croscopy (AFM), which allows us to directly observe the
oligomerization state of the protein (Figure 3A). Previous
studies showed that there is a linear relationship between
the molecular mass of a protein and its observed volume
in AFM images, allowing oligomerization state and asso-
ciation constants of protein–protein complexes to be de-
termined (31,32). Plots of the distribution of volumes of
DmGen deposited at 20 and 37 nM DmGen show a ma-
jor peak consistent with the volume expected for a DmGen
monomer and a smaller peak consistent with the volume
expected for aDmGen dimer (Figure 3A and Supplemental
Figure S8). Due to the low population of dimer and crowd-
ing of the protein on the surface, accurate determination
of the protein dimerization constant is not possible; how-
ever, based on the population of protein contained within
the monomer and dimer peaks, we estimate the protein dis-
sociation constant to be in the hundred nanomolar range
(Supplementary Figure S7).
To determine the affinity and stoichiometry of DmGen
binding to DNA, we used electrophoretic mobility shift as-
says (EMSAs) (Figure 3B and C). We incubated increasing
concentrations of DmGen (0.1 pM–10 nM) with 50 pM of
either 5′ flap or HJ0 in the presence of EDTA to chelate
the metal ions to prevent cleavage of the substrate. On the
HJ0, two slower-migrating bands appear with increasing
DmGen concentration, with the first shifted species occur-
ring at concentrations ofDmGen between 100 and 500 pM,
followed by complete conversion to a supershifted species
by 10 nM DmGen (Figure 3B), These results are consistent
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Figure 2. DmGen is a structure-specific endonuclease and a resolvase. (A) Substrates radiolabelled at the 5′ end of one strand (asterisks) were incubated
with full-length (FL) DmGen or truncated (518) DmGen. Arrows indicate sites of cleavage determined by denaturing PAGE, as shown below. The bracket
indicates the expected size range of the cleavage products for the HJ12 substrate. (B) Schematic illustrating the cleavage and ligation experiment of the
HJ0+10nt substrate formed by annealing one labeled strand of ∼50nt, one unlabeled strand of ∼50nt, and two unlabeled strands of ∼60nt. The addition
of ∼10nt on one arm are indicated in green and the asterisk indicates the location of the radiolabel. Cleavage with DmGen creates nicked duplex DNA
that can be ligated to create duplex DNA. When visualized on a denaturing PAGE, the presence of a newly ligated longer strand can be observed. (C)
Denaturing PAGE of HJ0+10nt cleavage and ligation experiment depicted in (B). (0) indicates substrate only and (+) indicate the addition of DmGen and/
or T4 ligase. Cartoons on the right of gel indicate the various products formed. Analysis of the cleavage and ligation products of the HJ0+10nt substrate
reveals ∼55% detectable product after cleavage. Incubation of cleavage products with T4 ligase shows a new 60nt band (30% of total) and a reduction of
the cleaved product (25% of total).
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Figure 3. DmGen can dimerize. (A) Topographical AFM images of truncated DmGen showing monomers and dimers. 20 nM truncated DmGen was
deposited onto naked mica and imaged with tapping mode AFM in air. The gradient bar represents 0–1.2 nm height above the mica surface. Yellow
arrows denote DmGen dimers. 1 m x 1 m images and volume analyses can be found in Supplementary Figure S8. (B) EMSA analysis of DmGen with
HJ0. Truncated DmGen (0.1, 0.5, 1, 5, 10, 50, 100, 250, 500, 1000, 10 000 pM) was incubated at room temperature with 50 pM radiolabeled DNA in the
presence of EDTA and bound products were separated using 4% native PAGE at 4◦C. The HJ0 cartoon indicates the position of the DNA alone, whereas
the positions of the HJ0 bound by monomer and dimer are indicated by a solid arrow and a dashed arrow, respectively. (C) The same as in (B), except
with the 5′ flap. Plots graphing the fraction of DNA bound as a function of DmGen concentration for three to four independent EMSAs can be found in
Supplementary Figure S9.
with DmGen binding to HJ0 with high affinity, similar to
those seen with CtGEN1, which binds to HJs with a high
affinity (∼10 nM) . We determined the DmGen concentra-
tion at which half of the substrate is bound (K1/2,EMSA,HJ) by
plotting the fraction of DNA bound (both shifted bands)
as a function of DmGen concentration for four indepen-
dent EMSAs and fitting them to the Hill equation (Supple-
mentary Figure S9A). This analysis yields aK1/2,EMSA,HJ for
binding of DmGen to the HJ0 equal to 0.19 ± 0.24 nM. In
addition, at 10 nM DmGen, all of the DNA is in the super-
shifted band, consistent with 100% of the HJ0 being bound
by a dimer or two monomers of DmGen (Figure 3B).
Interestingly,DmGen also forms two shifted species on a
5′ flap substrate (Figure 3C), with the first shifted species
occurring at concentrations of DmGen between 100 and
500 pM, followed by complete conversion to a supershifted
species by 1 nM DmGen (Figure 3C). The K1/2,EMSA,5’FLAP
for the 5′ flap substrate determined from three independent
experiments is 0.18 ±.08 nM. By 1 nM DmGen, all of the
DNA is in the supershifted band (Figure 4B and Supple-
mentary Figure S9B). The supershifted (dimer) band is un-
expected because for HsGEN1 a monomer is sufficient for
5′ flap cleavage (9). No band shifts were observed when the
same experiment was performed with linear dsDNA (Sup-
plementary Figure S9C), indicating that the supershifted
bands do not result from nonspecific binding of DmGen to
the DNA.
DmGen cleaves 5′ flaps faster than Holliday junctions
We investigated the kinetics of flap and HJ0 cleavage by
DmGen as a function of both substrate and enzyme concen-
tration inmultiple-turnover assays (i.e. excess substrate rela-
tive to protein) (Figure 4A andB). 5 nM5′ flap is completely
cleaved within 1–4 min using DmGen concentrations rang-
ing from 0.5 to 3 nM (10- to 1.7-fold excess DNA), with the
rate of cleavage increasing with increasing concentration. In
contrast, the rates of HJ0 cleavage are∼10-fold slower, with
reactions taking 10–30 min to plateau (Figure 4B). The re-
action containing 3 nMDmGen goes to completion, but re-
actions with the lower concentrations (0.5–1 nM) plateau at
20–60% of the substrate being cleaved, respectively (Figure
4B). Enzyme death, substrate inhibition and product inhi-
bition can result in <100% of the substrate being cleaved.
The observation that DmGen can completely cleave the 5′
flap at the same concentrations (Figure 4A) and that the
plateau levels decrease as the HJ0:DmGen ratio increases
(i.e. increasing HJ0 concentrations exhibit decreasing prod-
uct formation; Figure 4B) suggest that the excess HJ0 may
be inhibiting the reaction. This suggestion is supported by
our observation that the monomer of DmGen binds more
tightly than the dimer. Consequently, as the HJ0 concentra-
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Figure 4. DmGen cleaves 5′ flaps faster than HJs. Graphs show time courses of nuclease progression under conditions of excess (A) 5′ flap or (B) HJ0.
For each time course, aliquots were taken at various time points (note that the time scales differ in each panel). The intensity of each cleavage product
was quantified by ImageQuant, and the data were normalized to the expected amount of detectable product (see Experimental Procedures). Each point
represents the mean of three experiments, except in (A), which is the mean of two experiments. Error bars indicate standard error of the mean. The curves
drawn though the data are best fits to single exponentials (C) The rate of cleavage as a function of DmGen concentration under conditions of excess
DmGen. The data from each individual replicate in (A and B and Supplementary Figure S10) were fit to a single exponential curve given by the equation
y = m1*x /(m2 + x), where m1 = maximum rate (kapp,max) at saturating protein concentrations and m2 = the apparent dissociation constant (K1/2). Note
that the first point (3 nM protein) was performed with 5 nM 5′ flap or HJ0, whereas the rest of the experiments (20, 60, 100 and 200 nM protein) were
performed with 2 nMDNA. From these fits K1/2 and kapp,max are 62 ± 3 nM and 46 ± 9 s−1 for the flap and 660 ± 500 nM and 31 ± 19 s−1 for the 5′ flap
and HJ0, respectively.
tion increases above the concentration of DmGen, the ex-
cess HJ0 acts as a trap, binding monomers of DmGen and
removing them from solution, thereby reducing the con-
centration of active substrate-dimer complexes. HsGEN1
shows similar inhibition of cleavage when the HJ substrate
is in excess (9,43). We do not observe such substrate inhibi-
tion with the flap, likely because flap cleavage requires only
a monomer of DmGen.
Classic steady-state enzyme kinetics (multiple turn-over
assays) allow for the determination of the kcat and Km of
an enzyme by plotting the rate of reactions as a function
of substrate concentration. Because substrate inhibition oc-
curs if the concentration ofDmGen is below the concentra-
tion of HJ0 substrate, such assays could not be performed.
To circumvent the problem of substrate inhibition, we mea-
sured rates of cleavage of the flap and HJ0 as a function
of DmGen concentration, maintaining DmGen in excess
over substrate (Figure 4C and Supplementary Figure S10).
The rates measured in these reactions are the rate at which
DmGen cleaves a single substrate molecule and therefore
represent steps at or before cleavage. To determine the de-
pendence of the cleavage rate onDmGen concentration, we
first determined the pseudo-first-order rate constants, kapp,
by fitting the rate curves for each DmGen concentration
to single exponentials and then plotted kapp as a function
of DmGen concentration. The rate of cleavage (or kapp) of
both the flap and HJ0 as a function of DmGen concentra-
tion are fit well by simple hyperbolic binding curves, allow-
ing us to determine the K1/2,KINETIC (DmGen concentration
necessary to achieve half maximal cleavage rate or simply
‘apparent affinity’) and the apparent maximal cleavage rate
(Figure 4C). The K1/2,KINETIC and apparent maximal cleav-
age rates are 62 ±3 nM and 46 ± 9 s−1 for the flap and 660
± 500 nM and 31 ±19 s−1 for the HJ0, respectively. In all
concentrations ofDmGen tested, the rate of 5′ flap cleavage
is least∼7-fold greater than the rate of HJ0 cleavage (Figure
4C). These results are in striking contrast to the published
data onHsGEN1. Published studies onHsGEN1 using ex-
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cess protein found that HsGEN1cleaves a HJ more rapidly
than a 5′ flap, suggesting that HJs are preferred substrates
over 5′ flaps forHsGEN1 (9). In contrast, our data suggest
that 5′ flaps may be the preferred substrates for DmGen.
HsGEN1 cleaves 5′ flaps faster than HJs
We next determined whether the difference in substrate
specificity of DmGen and HsGEN1 may reveal a bona fide
difference in enzyme activity between the orthologs or may
result from dissimilar assay conditions (buffer andDNA se-
quence of substrates). The published study onHsGEN1 (9)
employed a low-salt phosphate buffer (referred to here as
Rass buffer), whereas we used a medium-salt Tris buffer
(Bellendir buffer); in addition, the sequences of the sub-
strates were different in the two studies (Figure 5A). Con-
sequently, we compared HsGEN1 with DmGen side-by-
side. The human and Drosophila proteins cleave each sub-
strate (5′ flap and HJ created from Bellendir or Rass oli-
gos) at the same site (Supplementary Figure S5). DmGen
and HsGEN1 have very similar rates of cleavage on both
HJ substrates in both buffers (Figure 5B, dark blue and
light blue bars); however, rates of 5′ flap cleavage vary with
sequence and with buffer. In the Bellendir buffer, the two
proteins have similar cleavage rates on both 5′ flap sub-
strates, and 5′ flap cleavage is significantly faster than HJ
cleavage (Figure 5B). In the Rass buffer, cleavage rates dif-
fer for the two sequences, with a 34-fold and a 6-fold dif-
ference between the highest and lowest rates of flap cleav-
age for HsGEN1 and DmGen, respectively (Figure 5B and
Supplementary Table S3). In summary, DmGen cleaves 5′
flaps faster than HJs in all conditions tested, andHsGEN1
cleaves 5′ flaps faster in all but one of the conditions we
tested (Figure 5B and Supplementary Table S3). Thus, vary-
ing the buffer conditions and oligo sequences used in ki-
netic assays reveals additional properties of HsGEN1 be-
yond those described previously. These results suggest that
simpler branched substrates, such as flaps, are preferred by
both DmGen and HsGEN1 and that both enzymes utilize
similar mechanisms of recognition and cleavage.
The rate-limiting step of HJ0 cleavage is assembly of a pro-
ductive dimer complex on the substrate
Examination of the DmGen kinetic data together with the
EMSAs can shed light onto possible mechanisms of 5′ flap
and HJ cleavage. Given that the EMSAs show very tight
binding of a DmGen monomer (K1/2,EMSA ∼ 0.2 nM) to
both the flap and theHJ0 (Figure 3B–C and Supplementary
Figure S9), it is likely that the concentration dependence of
the cleavage rate that we observe (Figure 4C) results from a
second monomer of DmGen binding to the substrate prior
to cleavage. From our EMSAs, we estimate that the con-
centration for a second monomer binding to either the HJ0
or the 5′ flap is 0.5–10 nM. The K1/2,KINETIC,5’FLAP for the
flap from our kinetic data is slightly larger than would be
predicted for dimerization on the 5′ flap from the EMSAs,
but this difference may be due to the different temperatures
at which the two experiments were performed (EMSAs at
4◦C and kinetic assays at 25◦C). The K1/2,KINETIC,HJ for the
HJ0 (660 nM), however, is significantly larger than apparent
Figure 5. DmGen and HsGEN1 cut 5′ flaps faster than HJs in a variety
of reaction conditions. (A) Schematic showing the substrates and reaction
buffers tested. The substrates shown in red and dark blue are those used in
our experiments (‘Bellendir oligos’), and those substrates in magenta and
cyan are from the previous published study onHsGEN1 (‘Rass oligos’) (9).
The sequences of central nucleotides near the branch points are shown in
black. The buffer components of the Bellendir and Rass buffers are listed
below the respective oligos. (B) A bar graph showing the first order rates
of cleavage on either Bellendir substrates (5′ flap-B andHJ-B) or Rass sub-
strates (5′ flap-R and HJ-R) in either the Bellendir Buffer or Rass Buffer
by DmGen (at 25◦C) or HsGEN1 (at 37◦C). Colors for each substrate cor-
respond to (A). Note that the final two bars are from experiments done in
the same conditions of previously published data in (9). Each rate was de-
termined from the average of≥3 time courses (0 s–10min or 30min). Error
bars are for the standard deviation of each mean rate. For rate values, see
Supplementary Table S3.
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binding affinities for the dimer seen in the EMSAs, in which
we observe 100% dimer at 10 nMDmGen. These differences
indicate that the K1/2,KINETIC,HJ value for the HJ0, deter-
mined from kinetic measurements represents a step other
than the binding seen in the EMSAs.
If the rate-limiting step to HJ0 cleavage is a confor-
mational change after binding, the weak K1/2,KINETIC,HJ
(660 nM) we observe for cleavage of the HJ0 could rep-
resent nonspecific of binding of the second monomer of
DmGen prior to a conformational change that leads to
the stable DmGen2:HJ0 complexes seen in the EMSAs. To
test this possibility, instead of adding DNA, DmGen, and
Mg2+ simultaneously as done above (Figure 4A–C), we pre-
incubated DmGen with HJ0 in the absence of Mg2+, allow-
ing time for the dimer to assemble on the HJ0, then ini-
tiated cleavage by the addition of Mg2+ (Figure 6). If the
rate-limiting step is conformational change after the sec-
ond monomer binds the HJ0 (i.e. productive assembly of
the dimer on HJ0) that results in a stable DmGen2:HJ0
complex that is slow to dissociate, a burst of rapid cleav-
age with an amplitude equal to the concentration of pre-
formedDmGen2:HJ0 complexes will be observed in the pre-
incubation experiment (47). Using 3 nM DmGen with of 5
or 10 nMHJ0, we observe a burst of cleavage before the first
time point (5 s), followed by a slow rate of cleavage similar
to that seen in the simultaneous addition experiment (Fig-
ure 6A andB). This observation strongly suggests that given
sufficient time, DmGen can cooperatively assemble into a
productive complex on the HJ0. We used a DmGen con-
centration of 3 nM, corresponding to 1.5 nM dimer with 5
or 10 nM HJ0. If all the DmGen molecules were active and
pre-bound as dimers to HJ0 and poised to undergo cleav-
age, wewould expect burst heights of 30% for 5 nMHJ0 and
15% for 10 nMHJ0. We observed burst heights of 28% and
10%, respectively (Figure 6A), suggesting that the majority
of DmGen is active and bound in a productive dimer com-
plex prior to the addition of Mg2+. These results are consis-
tent with our equilibrium binding EMSAs, which suggest
that the binding affinity of a dimer of DmGen for the HJ0
is between ∼3 and 10 nM (Figure 3B). Taken together, our
results strongly suggest that the rate-limiting step to HJ0
cleavage is a conformational change after binding of the
second monomer ofDmGen to the HJ. We conducted simi-
lar pre-incubation experiments with the flap (Figure 6C). In
contrast to the results of pre-bindingwith theHJ0, no initial
burst of cleavage is discernable, suggesting that the interac-
tion ofDmGen with the flap is dynamic and that binding of
a monomer or dimer to the flap does not result in a complex
that is slow to dissociate (Figure 6C and 6D).
DISCUSSION
In this work, we show that DmGen functions as a key
structure-selective endonuclease (SSE) during repair of
DNA damage. Our genetic data reveals a fundamental dif-
ference betweenDmGen and the well-characterized human
and fungal orthologs. In Drosophila, Gen single mutants
have extreme hypersensitivity to DNA damaging agents but
mus81 single mutants do not (Figure 1); as in other organ-
isms, mus81 Gen double mutants have even more severe hy-
persensitivities. These data are in stark contrast to genetic
results seen in other species, where Mus81 is the predom-
inant SSE and Gen orthologs play a secondary role in re-
pair (17,19,20,35). Interphase protein localization does not
appear to account for the reversed dominance observed in
Drosophila, asDmGen, likeYen1 andHsGEN1, seems to be
primarily or exclusively cytoplasmic (Supplementary Fig-
ure S2) (40,48,49); however, it is possible that the order of
activation during mitosis is switched in Drosophila relative
to yeast and human cells.
DmGen, like HsGEN1, cleaves a variety of branched
structures including 5′ flaps, replication forks, splayed arms
and HJs (Figure 2 and Supplementary Figure S5). The
mechanism of HJ cleavage appears to be similar between
DmGen and HsGEN1, as the two proteins exhibit similar
rates of cleavage across various conditions (Figures 5–7).
Both DmGen and HsGEN1 are robust 5′ flap endonucle-
ases. HsGEN1’s cleavage rate on flaps is more sensitive to
reaction conditions than that of DmGen, though even this
difference might be due to different physiological temper-
atures (Figure 5). This combination of genetic differences
and biochemical similarities observed betweenDmGen and
HsGEN1 highlights the unique platform that Drosophila
provides to the DNA repair/structure selective endonucle-
ase fields to further our understanding of the functions of
these enzymes in vivo. Below, we discuss insights into the
mechanism of cleavage of HJs and flaps by DmGen or-
thologs, structural considerations that may underlie novel-
ties across DmGen orthologs, and the importance of HJs
versus other substrates.
The mechanism of 5′ flap and HJ cleavage by DmGen
Comparison of our biochemical data withDmGen to those
with the yeast and human orthologs suggests that they fol-
low similar mechanisms of cleavage of 5′ flaps and HJs.
Taking both our kinetic and EMSA data into account al-
lows us to elucidate important features of the mechanism
of HJ and 5′ flap cleavage. HJ cleavage requires the assem-
bly of a dimer of DmGen (or orthologs) on the HJ prior
to cutting (9,43,45,46). Our prebinding experiments (Fig-
ure 6A), which reveal a burst of cleavage followed by a
slow turnover, indicate that after the secondmonomer binds
the complex undergoes a conformational change that stabi-
lizes theDmGen2:HJ0 complex and leads to rapid cleavage.
These data support previous models for the activity of or-
thologs on HJs, which suggest that a rate-limiting confor-
mational change occurs after binding of a second monomer
(9,43,45,46). Our EMSAs show tight binding of both the
monomer and dimer of DmGen to the HJ (Figure 4A and
Supplementary Figure S9). Our observation of HJ0 sub-
strate inhibition further supports tight monomer binding,
and the near-stoichiometric burst amplitudes in prebinding
experiments support tight dimer binding; however, in ex-
periments in which DmGen, DNA, and Mg2+ were mixed
simultaneously, we observe a very weak concentration de-
pendence of DmGen for HJ cleavage, with a K1/2,KINETIC
consistent with nonspecific DNA binding (Figures 4B and
6A). Accordingly, we propose that the first monomer binds
tightly to theHJ (K1/2,EMSA ∼ 0.2 nM), followed by a second
monomer binding with a weak affinity (K1/2,KINETIC ∼ 700
nM) to form a nonspecific dimer on the HJ (Figure 7A).
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Figure 6. Production of an active complex is the rate-limiting step in HJ0 cleavage. (A) To determine whether the rate-limiting step of the HJ0 reaction
is a slow conformational change that results in a stable Gen2:HJ0 complex that can rapidly cleave the DNA, 3 nM DmGen was pre-incubated with 5 or
10 nM HJ0 for several minutes before starting the time course experiment with MgCl2. Quantification and analyses were done as in (Figure 4A–C). (B)
Data from the corresponding simultaneous addition experiments in Figure 4B (3 nM DmGen with 5nM HJ0, pink) is replotted on a 1-minute time scale
for comparison to (A). (C) The same as in (A), except with the 5′ flap. (D) Data from the corresponding simultaneous addition experiments in Figure 4A
(3nM DmGen with 5nM 5′ flap, pink) was replotted on 1-minute time scale for comparison to (C). Note that the data in this figure are not normalized, as
in Figure 4.
Subsequently, this complex undergoes a rate-limiting con-
formational change that positions opposing DNA strands
in theDmGen active sites to form a stable productive dimer-
HJ0 complex that is slow to convert back to the nonspecif-
ically bound form. After formation of a productive dimer–
HJ complex, the dimer rapidly nicks the two opposing
strands of the junction in a cooperative and symmetricman-
ner, yielding two nicked duplexes. It is also possible that a
DmGen dimer can form in solution prior to binding the
HJ (Figure 7A, bottom left box); however, our results in-
dicate that the HJ must be in the proper conformation for
the second DmGen to bind tightly. The importance of the
HJ conformation is also supported by the crystal structure
of CtGEN1 bound to an HJ after cleavage. In the presence
of cation, unbound HJs are found in the stacked X confor-
mation (50). In the HJ model based on the crystal structure
of CtGEN1 in the product complex, the HJ is bent into
a non-planar conformation (46). Given the affinity of the
monomer for DNA, binding of preformed dimers to the HJ
may promote dissociation of one monomer. It is also pos-
sible that a DNA conformational change occurs prior to a
second DmGen monomer binding the HJ (Figure 7A, top
right box).
Consistent with data on HsGEN1 (9,43), our EMSA
data taken together with our kinetic data on the 5′ flap
under excess substrate conditions suggest that a monomer
of DmGen can cleave a 5′ flap. This result is not unex-
pected, as flap cleavage requires only a single nick. Our ki-
netic data using excess protein further suggest that a second
monomer ofDmGen can bind to the flap (with an apparent
affinity/K1/2,KINETIC,5’FLAP of 60 nM) and increase the cat-
alytic activity (Figure 4). This latter observation suggests
that the rate-limiting step for flap cleavage is a conforma-
tional change that places the 5′ flap in the proper orientation
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Figure 7. Mechanism of DmGen cleavage of HJs and 5′ flaps. (A) Mechanism of Gen function on HJs. DmGen monomer binds the HJ with a KD of ∼0.2
nM (K1/2,EMSA,HJ from EMSAs), followed by weak, nonspecific binding of a second monomer with a KD of ∼660 nM (K1/2,KINETIC,HJ from Kinetics).
Formation of a productive dimer complex, exhibiting the correct DNA conformation required to position opposite DNA strands in theDmGen active sites,
is slow. Once a productive dimer–HJ0 complex is formed, the dimer cooperatively nicks across the junction. (bottom left box) It is unlikely that a pre-formed
dimer will encounter a HJ exhibiting the proper conformation required for cleavage. If the dimer–DNA complex is not productive, one monomer likely
dissociates from the HJ, allowing otherDmGen proteins access to the junction. (top right box) It is also possible that a DNA conformational change occurs
prior to the second monomer binding; however, given our observation that production of a productive dimer–DNA complex is the rate-limiting step, this
is unlikely to represent a main pathway. See discussion for additional details (B) Mechanism ofDmGen function on 5′ flaps. (top)DmGen monomer binds
the 5′ flap, triggering a DNA conformational change and rapid cleavage of the flap strand one nt 3′ of the junction branch point. (bottom) A Drosophila-
specific pathway is depicted in the box. (i) A pre-formed dimer can bind the 5′ flap, (ii) Alternatively, two monomers can sequentially bind the 5′ flap,
with the first monomer having a very high affinity (∼0.2 nM from EMSAs) and the second monomer having a weaker affinity of ∼ 60 nM (based on the
K1/2,KINETIC, 5’ flap determined from kinetic data). The additional DNA contacts provided by the second monomer may constrain the 5′ flap conformation
to facilitate cleavage.
for cleavage and that the dimer facilitates this change. Based
on these observations we propose the mechanism shown in
Figure 7B. A DmGen monomer binds the 5′ flap with high
affinity (K1/2,EMSA ∼0.2 nM, based on EMSAs), followed
by a conformational change that positions the DNA in the
active site and the subsequent rapid cleavage of the 5′ flap
one nucleotide 3′ of the branch point (Figure 7B, top). At
low DmGen concentrations or in excess substrate, this path
dominates; however as the concentration of DmGen in-
creases, a secondmonomer or a preformed dimer ofDmGen
can bind the 5′ flap and increase the rate of cleavage ∼ 5–10
fold. This proposed mechanism is supported by our obser-
vation thatDmGen can formdimers in solution and that the
rate of flap cleavage increases with DmGen concentration,
with aK1/2,KINETIC = 60 nM (Figures 3, 4, 5 and Supplemen-
tary Figures S7-10). We suggest that this K1/2,KINETIC repre-
sents the binding affinity of the secondmonomer ofDmGen
to the flap (Figure 7B, (ii)). The additional DmGen–DNA
binding interactions provided by the second monomer may
help to constrain the DNA, facilitating the DNA confor-
mational change that positions the flap strand in the active
site of the other DmGen monomer. This second monomer,
while not necessary for cleavage, can be equated to the role
of the scaffolding protein SLX4. Although SLX4 does not
harbor nuclease activity, it not only increases the cleavage
rates of SAs by XPF-ERCC1, but also increases prefer-
ence of XPF-ERCC1 for SAs over stem–loops or bubbles
(51). Interestingly, examination of publishedEMSAdata on
Yen1 (Figure 6E from (40)) binding to 5′ flaps reveals that
dephosphorylated Yen1 exhibits two shifted bands similar
to our results withDmGen. These results suggest that Yen1
can also dimerize on 5′ flaps as well as HJs. It remains to be
investigated whether other orthologs can also dimerize on
flaps.
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Protein structural comparisons across Gen orthologs high-
light differences leading to substrate specificity and dimeriza-
tion
Studies ofDmGen orthologs across species show cleavage of
a variety of branchedDNA structures and different propen-
sities for dimerization. Insight into possible structural rea-
sons for these differences in biochemistry can be gleaned
from analysis of the protein primary sequences and crys-
tal structures of the DmGen orthologs and the 5′ flap cut-
ter FEN1, which is a monomeric family member. Sequence
alignment of the DmGen and FEN1 orthologs reveals sig-
nificant differences among the orthologs in the region of
DmGen 76–125 (Supplementary Figure S11). This region
is adjacent to the active site and forms part of the dimer in-
terface in the crystal structure ofCtGEN1and the proposed
dimer interface of HsGEN1 (45,46). In FEN1, this region
forms a helical arch with a cap through which the single-
stranded 5′ flap is threaded. It has been suggested that this
cap would prevent DNA structures without free ends from
threading into the catalytic site, thereby limiting the activity
of FEN1 to substrates containing a single-stranded 5′ end
(46,52). In CtGEN1, both the arch and cap regions are ab-
sent, and the protein is predominately a monomer in solu-
tion and cuts HJs but not flaps, replication forks or splayed
arms . In HsGEN1, only the cap region is absent; the pro-
tein is a monomer in solution, but it cleaves 5′ flaps, repli-
cation forks, HJs, and splayed arms (Supplementary Fig-
ure S5). Flap cleavage byHsGEN1 shows greater sensitivity
than DmGen to the buffer and to the sequence at the junc-
tion (8,45,53).DmGen has both the helical arch and cap (al-
though the cap sequence is not conserved with FEN1); this
protein can dimerize on substrates and can cut 5′ flaps, repli-
cation forks, HJs, and splayed arms. Interestingly, Yen1 also
contains both the helical arch and cap region, and it cuts
5′ flaps, replication forks, and HJs, but not splayed arms,
and appears to dimerize on flaps (Figure 6E from (40)).
Taken together, these observations suggest that the presence
and/or the sequence of helical arch and cap govern not only
substrate specificity but also the propensity to DmGen and
its orthologs to dimerize. The ability of DmGen to dimerize
on substrates as well as its broad substrate specificity may
contribute to its preferential usage over Mus81 in vivo.
Substrate specificities of DmGen and HsGEN1 suggest that
HJs are uncommon repair intermediates
Although it may seem unusual for the roles of Gen and
Mus81 to have switched in Drosophila relative to other
species, comparison of the in vitro and in vivo activities of
DmGen in flies and Mus81 in other species sheds light on
the commonalities of these two enzymes that allow them to
be interchangeable within cells. The predominant enzymes
in flies (DmGen) and in yeast and human cells (Mus81) cut
a variety of branched structures, with substantially higher
activities on simpler structures, such as flaps, over the more
physically restrained HJ. While DmGen and its orthologs
cut 5′ to a branch point andMus81 cuts 3′, this polarity dif-
ference may be less relevant in vivo and may simply dictate
the orientation of binding of the endonuclease to the sub-
strate. This suggestion is supported by in vitro data that indi-
cate that both Mus81 and DmGen orthologs cleave nicked
HJs and replication forks to form nick duplexed products
(9,54,55). In addition, in vivo studies show that overexpres-
sion of Yen1 can rescue mus81 mutants in budding yeast
(17), and expression of HsGEN1 or DmGen can rescue
mus81mutants in fission yeast, which lacks a Yen1 ortholog
((40) and Supplementary Figure S1). We propose that these
simpler structures may be more important in vivo, perhaps
because they are more frequently encountered. Consistent
with this hypothesis, recent studies show that replicative
stress in yeast results in nicked and gapped HJs, while an-
other study highlights non-HJ intermediates of replication
repair (56,57).
In repair, DNA intermediates arising from strand ex-
change that generates a displacement-loop (D-loop) resem-
ble flaps or nicked HJs, and these intermediates have many
potential advantages over a canonical HJ as substrates for
SSEs. First, flaps or nHJs would presumably be an earlier
intermediate in repair, and further synthesis and ligation
would require additional energy. Second, flaps or nHJs only
require one nuclease domain for cleavage and could explain
why eukaryotic ‘resolvases’ are predominantly monomers
or heterodimers with only a single catalytic subunit. These
points suggest that there may be mechanisms to avoid
formation of HJs in favor of less complex intermediates.
Nonetheless, intact HJs may accrue if repair intermediates
are not processed fast enough such that further synthesis
and ligation occurs, or if blocked replication forks are re-
gressed (58). Even so, the biological presentation of these
intact HJ may be very different from the synthetic in vitro
HJs used for testing cleavage activity. In vivo, intact HJsmay
be opened by helicases or ssDNAbinding proteins, and con-
sequently resemble the splayed arms or bubbles studied in
vitro. Such intermediates have been proposed to explain the
requirement for the Blm helicase tomakemeiotic crossovers
inC. elegansmeiosis (59). Accordingly, we propose that dur-
ing damage repair, canonical resolvase activity of Mus81
and DmGen orthologs on intact HJs may be a backup or
failsafe to resolve intact HJs if they accumulate, but the pri-
mary role of these endonucleases is to cleave other struc-
tures that arise.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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